Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 26 | $9,313,269 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
13 Nov 2024 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 11 Nov 2024 | Sale | 3,000 | 518.27 | 1,554,810 | D |
05 Jun 2024 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 03 Jun 2024 | Sale | 3,250 | 460 | 1,495,000 | D |
30 May 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 28 May 2024 | Sale | 3,250 | 454.79 | 1,478,068 | D |
04 Jan 2024 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 Jan 2024 | Sale | 3,000 | 405 | 1,215,000 | D |
21 Nov 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 20 Nov 2023 | Sale | 3,000 | 349.88 | 1,049,640 | D |
28 Mar 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 24 Mar 2023 | Sale | 1,768 | 305.38 | 539,912 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 16 | 301.13 | 4,818 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 240 | 299.58 | 71,899 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 360 | 298.09 | 107,312 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 240 | 296.3 | 71,112 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 784 | 295.43 | 231,617 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 360 | 294.52 | 106,027 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 62 | 296.77 | 18,400 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 292 | 295.89 | 86,400 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 715 | 294.52 | 210,582 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 1,153 | 293.35 | 338,233 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 420 | 292.41 | 122,812 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 24 | 288.31 | 6,919 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 102 | 294.94 | 30,084 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 27 | 293.61 | 7,927 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 185 | 292.68 | 54,146 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 541 | 291.47 | 157,685 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 30 | 289.44 | 8,683 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 327 | 288.91 | 94,474 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 515 | 287.83 | 148,232 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 361 | 286.64 | 103,477 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)